As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Oral vs injectable GLP-1 RAs: dosing and adherence Administration options for GLP-1 receptor agonists include daily oral tablets (semaglutide), daily injections (liraglutide, lixisenatide), and weekly injections (semaglutide, dulaglutide, exenatide-ER)
PMID: 30312372
GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use
Start your intake How Magnesium Affects Digestive Function During GLP-1 Therapy Magnesium plays a critical role in muscle contraction and nervous system signaling throughout the digestive tract